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During much of this century, Americans have
welcomed the technological developments, clinical
breakthroughs, and miracle drugs that have produced
the most highly regarded health care in the world. Over
time, however, the magnitude of national healthcare
expenditures has led to questions about whether more
always means better and whether patient needs are
being met in the best way possible. During the 1970s,
rising Medicare costs led to demands for stricter hospital utilization review, in turn prompting concerns about
the impact of cost containment on quality.
In the 1970s and 1980s, health services research by
John Wennberg and others identified substantial geographic variations in patterns of care, showing that
medical decision-making by physicians often depended
more on the supply of local resources and on prevailing
local practice styles than on science. Other research
called into question the appropriateness of up to onethird of all health care interventions, indicating that
those procedures either had little impact on patients’
health or were potentially harmful to patients.1
Concerns about quality mounted even higher with
the 1986 release by the Health Care Financing Administration (HCFA) of its first provider “report card” of
risk-adjusted, hospital-specific data on Medicare
mortality rates. Although this report created much
controversy and criticism of the methodology used, it
did raise awareness and demonstrate significant variations in patient outcomes among hospitals. Congress
entered into the evaluative spirit when it authorized and
funded Professional Standards Review Organizations to
review the quality as well as utilization of Medicare
services.
The quality of health care, it appears, has always
been inconsistent; it is only recently that awareness of
inconsistency has become widespread. This observation
runs counter to a popular tendency to associate poor
quality with the spread of managed care and its perceived limits on consumer choice. In fact, evidence can
suggest that managed care is as good as, worse than, or
better than fee-for-service care—depending on which
research one turns to.2
Answers to questions about how to define, monitor,
and assure health care quality have proven elusive. For
more than a decade, various sectors of the industry have
pursued an approach based on the concept of accountability—the idea that health plans, insurers, hospitals,
physicians, and other providers should take responsibility for their activities by demonstrating the quality and

value of their services. Central to this strategy is the
production, collection, and reporting of data designed
to measure different aspects of quality and performance.
Today, an abundance of data derived from a wide
range of measures is available from multiple sources for
multiple audiences. The landscape of health care quality
and performance measurement is a patchwork of
disparate activities at the national, state, and local
levels—some in the public sector, others in the private
sector, and still others that represent a collaboration
between the two.
But there is little sense of how the data from these
various initiatives fit together, what they reveal, and
what their limits are. How far do these multiple and
diverse approaches help advance the state of the art, and
how much do they merely muddy the waters? Do these
efforts add up to information that is actually useful to
the people who need it? Is there an infrastructure to
support the maintenance and dissemination of information? Will current efforts converge on recognizable
accountability across the healthcare system?
Like quality, accountability is not a cut-and-dried
concept. It involves several specific questions. Who is
to be held accountable? By whom? For what and how?
In health care, like other industries, numerous “loci” of
accountability—parties that can be held accountable or
hold others accountable—have been identified.3
“Accountors” may also be “accountees.” For example,
a hospital may evaluate the activities of its physicians
and, in turn, be open to scrutiny by government regulators, contracting health plans and insurers, employers,
and the public. Parties may be held accountable in
several distinct domains, including professional competence, legal and ethical conduct, financial performance,
accessibility, public health promotion, and community
benefit.4 Different actions, including government
sanctions, approval or denial of accreditation applications, and purchasing selections, may be used to establish accountability. Report cards that compare health
care providers and plans on specific outcome, process,
and service indicators have become a widely used
mechanism for establishing accountability. But, without
clear systems that identify the parties in accountable
relationships, the nature and scope of these relationships, and the procedures to be employed, accountability may well be in the eyes of the beholder.
This paper will discuss quality measurement and
reporting activities in three arenas of accountability:
professional, market-driven, and public-sector. By
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exploring the accomplishments and limitations in each
of these areas, it may be possible to develop a better
sense of how to invest in future efforts to assure health
care quality.

DOMAINS OF ACCOUNTABILITY
There is no single, unified audience for information
on health care quality, but rather a variety of audiences
with different—and sometimes conflicting—interests
and priorities. For example, consumers are interested in
information on providers—primarily at the hospital and
physician level—that will help them determine where to
seek care. Research shows that consumers also want
information on how to evaluate tradeoffs among cost,
quality, and access under different delivery options.5
Policymakers and regulators need information to help
them understand how the healthcare system is performing and to inform future legislation and regulation.
Purchasers—in both the public and the private sectors—want the greatest possible value for their healthcare dollars. Providers—including health systems,
plans, hospitals, and physician groups—are using data
to demonstrate and improve the quality of care they
provide, differentiate themselves to purchasers, and, in
some cases, select their contracting partners.
This diversity of needs and interests is reflected in
the multiple approaches under way to use health care
data to measure, identify, and demonstrate quality.
Three approaches will be surveyed in this background
paper:







The professional approach—relies on the actions of
private-sector accreditation groups, trade associations and health plans, hospitals, and other providers
to assure quality. The profession assumes leadership
for policing itself and demonstrating quality to
parties outside the profession.
The market-driven approach—relies on the use of
quality data by healthcare purchasers and consumers
in choosing plans and providers. The basic assumption is that quality is a market force on a par—or
nearly so—with cost.
The public-sector approach—relies on the regulatory, oversight, and purchasing actions of government at the federal, state, and local levels to assure
quality. Traditionally, government activities in
healthcare quality assurance have focused on regulation and oversight, but government bodies increasingly are taking advantage of opportunities to use

their purchasing power as an alternative or an
adjunct to regulation and oversight.
Activities going on in these spheres frequently
overlap. For example, the National Committee for
Quality Assurance (NCQA), a managed care accreditation group, is involved in several important data initiatives that figure prominently in activities under all three
of these models. HCFA’s quality measurement and
reporting efforts have expanded greatly during the past
year as it has begun to take advantage of its purchasing
clout. As a result, it is forging more collaborative
efforts with employers, consumer groups, and other
parties. It has also worked closely with NCQA to
develop versions of the widely used Health Plan Employer Data and Information Set (HEDIS) tailored for
Medicare and Medicaid.
The structures for establishing accountability reflect
different views of who is best suited for assuring healthcare quality, a question that ultimately centers on the
appropriate role of government. Market proponents
argue that the market itself can produce needed information and appropriate responses to assure quality without
government regulation. Others (including some market
theorists), contending that health care consumers can
never have or understand all the information they need
to make informed choices, advocate a profession-based
accreditation model. Healthcare analyst Michael L.
Millenson suggests that the approach developed by the
Federal Trade Commission (FTC) during the first term
of the Reagan administration could be applied to the
healthcare industry. Asked to explore how government
and the private sector could work together to make markets function better, the FTC identified several actions:
development of standardized measures and tests, education of consumers with respect to these standards, and
production of relevant information.6 Finally, many
people believe that some degree of government oversight or involvement will be required to assure healthcare quality, although they disagree on how much. The
1993 Clinton reform plan, for example, outlined a highly
regulated and multi-layered system of accountability, to
be presided over by a federally appointed body. A
proposal sponsored currently by Sen. Joseph I. Lieberman (D-Conn.) and Sen. Jim Jeffords (R-Vt.) takes the
view of government as an arbiter and clearinghouse for
information on quality. Meanwhile, the President’s
Advisory Commission on Consumer Protection and
Quality in the Health Care Industry is considering a
proposal for a two-tiered approach to healthcare quality,
in which a newly created body lodged in the public
sector would promote continuous quality improvement
activities throughout the industry and another entity
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housed in the private sector would concentrate on issues
related to the efficacy and effectiveness of different
quality measurement and reporting methods.

ACCOUNTABILITY IN A
PROFESSIONAL MODE
This approach encompasses the activities of health
care accreditation groups and professional associations.
In this model, quality standards are developed and
applied through voluntary accreditation programs,
although often these programs become directly or
indirectly mandated by states to satisfy licensing requirements, by HCFA as a condition of participation in
Medicare and Medicaid, or by private-sector purchasers.
Accreditation, the award by a recognized independent body of its own “seal of approval” to another organization, is probably the longest-standing form of external
healthcare quality assurance. These awards are generally
viewed as symbols of quality because they are based on
applicants’ ability to meet defined standards. Traditionally, those standards focused on structural assessments
of facility resources and capabilities. But changing
concepts of quality that emphasize outcomes and
process over structure, along with escalating demands
for useable quality data and concerns about the lack of
standardized and coordinated data collection, are
combining to effect changes in accreditation programs.
As a result, the healthcare accreditation industry,
like the healthcare industry itself, is undergoing significant change. The proliferation of new and complex
vehicles for healthcare delivery have prompted many
accrediting organizations to create new accreditation
programs, expand the scope of existing ones, and
develop new standards for quality.7
The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) is a good example.
Created in 1951 as the Joint Commission on Accreditation of Hospitals by the American Hospital Association,
the American Medical Association (AMA) and several
other physician groups, JCAHO today is an independent, not-for-profit organization that evaluates and
accredits more than 18,000 healthcare organizations and
programs in the United States. Its hospital accreditation
program, launched in 1953, has been the foundation of
JCAHO’s activities. But as the healthcare industry has
expanded and diversified, so have JCAHO’s accreditation programs, which now also cover health plans,
integrated delivery networks, and preferred provider
organizations; home care organizations; nursing homes

and other long-term care facilities; behavioral health
care organizations; ambulatory care providers; and
clinical laboratories.
For several years, JCAHO has worked to make
performance measurement a component of its accreditation process, beginning with the development of its
Indicator Measurement System (IMS). Initially, JCAHO
envisioned the IMS as the linchpin of its hospital
performance measurement program. But a series of
problems with the IMS forced JCAHO to redraw its
plans. Instead, in February 1997, JCAHO launched a
program called ORYX, which, according to Deborah
Nadzam, Ph.D., JCAHO’s director of indicator measurement, is designed in the short term to get “everyone
on the train.” Under ORYX, health care organizations
may choose from more than 100 data reporting systems,
including the IMS, that have been approved by JCAHO
for use in the program. They may also choose which
performance measures they will use. Nadzam notes that
there is still a great deal of confusion about performances measurement; over time, she adds, JCAHO
anticipates that ORYX will become more uniform.
The American Accreditation HealthCare Commission, Inc./URAC, which accredits PPOs, POS plans,
and other open-panel plans, also espouses a flexible
approach to outcome performance measurement. No
single measurement system can be appropriate for all
health plans, argues Gary Carneal, the organization’s
president, who cites structural differences among plans
and other methodological concerns. “This issue,” he
says, “reflects the classic debate involving the standardization of measurement indicators versus the need to
maintain some flexibility in a diverse marketplace while
at the same time maintaining accuracy.”8 AAHC/
URAC, which was chartered in 1990 as the Utilization
Review Accreditation Commission, Inc., and changed
its name in 1997, to date has granted about 350 company accreditations and issued 800 site accreditation
certificates. It is revising its network accreditation
standards to include some outcome performance
measurement “to provide benchmarks for comparing
plan operations,” Carneal says.
Yet despite confusion and disagreement on how best
to measure performance, the managed care industry has
been able to achieve a high level of consensus on
HEDIS, the Health Plan Employer Data and Information Set, the most widely used tool for evaluating health
plan performance. Launched in the late 1980s as an
employer initiative, HEDIS, and the responsibility for
maintaining and updating it, now resides with NCQA,
the leading accreditor of managed care plans. Cary
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Sennett, M.D., Ph.D., NCQA’s executive vice president, credits HEDIS with achieving a high level of
standardization by initially developing indicators that
were feasible and relatively simple for health plans to
report and increasing the complexity and sophistication
of new measures over time.9
NCQA was formed in 1979 by two managed care
trade associations, the American Managed Care and
Review Association and the Group Health Association
of America. (The two groups merged in 1995 to become the American Association of Health Plans.)
NCQA became independent in 1990 through a grant
from the Robert Wood Johnson Foundation and matching funds from health plans.10
NCQA develops new measures for HEDIS in
collaboration with purchasers, consumers, industry
representatives and quality experts. (NCQA calls this a
“stakeholder approach” to quality measurement.) It also
maintains a database on health plan performance. Its
work on HEDIS is separate from its accreditation
activities, since HEDIS reporting is not a requirement
for NCQA accreditation. However, plans for an integrated accreditation model partially driven by performance measurement are under way, according to
NCQA President Margaret E. O’Kane, who anticipates
that implementation will begin in July 1999.
Because of its broad view of its role in quality
assurance and performance measurement, NCQA has
become a major player in the employer-based value
purchasing movement and has engaged in many collaborative initiatives with purchasers, health plans, and
consumer organizations, most of which are centered
around HEDIS. For example, several regional business
and purchasing coalitions engage in the publication of
HEDIS “report cards,” which compare and report plans’
performance on specific HEDIS indicators. In California, the Pacific Business Group on Health (PBGH), a
preeminent purchasing coalition, joined with the
California Public Employees Retirement System to
establish the California Cooperative HEDIS Reporting
Initiative, which collects, analyzes, and reports plans’
HEDIS performance data.
Meanwhile, the AMA, which for many years resisted standardized attempts to evaluate the quality of
care provided by physicians, has developed a program
for individual physician accreditation. The American
Medical Accreditation Program (AMAP), announced in
1996, is designed to free physicians from the multiple
data demands and credentialling procedures of health
plans and other organizations by establishing a univer-

sally accepted process for certifying physician quality.
Work is under way to identify specific clinical performance and patient care indicators for an outcomes
component to this program. For now, AMAP requires
physicians to participate in a clinical performance
evaluation or continuous quality improvement (CQI)
initiative.
In general, the incorporation of outcomes-based
performance measures into professional accreditation
programs is still at an early stage. It is unclear when
these programs will begin holding plans and providers
accountable for their services on the basis of clinical
quality. Nor is it yet clear how this information will be
released to broader audiences, such as purchasers,
consumers, and policymakers, or how relevant it will be
to them in the healthcare choices they make.

THE MARKET-BASED APPROACH TO
ACCOUNTABILITY
In this sphere of activity, market demands for
comparative information about quality among competing plans and providers reflect purchasing decisions that
are based at least partly on quality. Large, private-sector
purchasers and regional purchasing coalitions are the
driving forces here, and market competition is their
mechanism for accountability. Quality may be ascertained either through performance data supplied by
plans and providers or through certain proxies for
quality, such as accreditation.
Employers are engaging in numerous data collection
activities aimed at increasing the value of the healthcare
services they purchase. Many of these efforts are
focused on the collection of HEDIS data. Some are
aimed specifically at identifying high-value plans and
providers. Employers may either contract exclusively
with those high performers or use financial incentives
to steer their employees toward superior plans and
providers. In addition, employers and purchasing
coalitions throughout the country are engaged in their
own initiatives to measure, compare, and promote
quality among the plans, hospitals, medical groups and
other health care entities with whom they do business.
Employers’ demands for information about quality
are increasing the pressure on health care plans and
providers to invest more heavily in improving their data
capabilities as a condition of doing business. This is
particularly true among those large purchasers—such as
Xerox Corporation, Digital Equipment Corporation,
General Motors Corporation, and ARCO, to name a
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few—who take a long-term view of health care purchasing, have sufficient market clout to force plans and
providers to meet their demands for data, and possess
the internal resources necessary to use those data. But
these companies are the exception, not the rule, and
they are far outnumbered by the thousands of smaller,
less powerful employers who still seem to purchase
health care almost solely on price.
In addition, a number of employer coalitions have
sprung up throughout the country, although “only a
handful of groups [are] actively contracting on the basis
of value,” according to a report by the National Business Coalition on Health.11 The report notes that coalition activities to measure and improve quality are
“slowly progressing,” but adds that this process must
accelerate if value-based purchasing is to become an
influential force in healthcare markets.
However, several coalitions are actively pursuing
“value purchasing” activities. For example, PBGH,
which represents 2.5 million covered lives from 33
private- and public-sector purchasers, uses a multipronged approach that involves collecting and analyzing health plan performance data to produce report
cards for consumers; promoting shared treatment
decision-making between providers and consumers; and
collecting, analyzing, and reporting data on consumer
satisfaction.12 In addition, PBGH was the first purchasing coalition to impose a condition on contracting plans
whereby it would withhold 2 percent of the premium
until the plans achieved specific goals for improving
customer satisfaction and quality of care. The Alliance,
a health insurance purchasing cooperative in Denver,
has adopted a similar approach. In Ohio, the employerdriven Cleveland Health Quality Choice (CHQC)
program has for several years measured and tracked
quality of care provided by area hospitals using riskadjusted measures of patient satisfaction, mortality,
length of stay, hospital complications, and cesareansection rates. Over time, CHQC has reported improvements in several of these indicators.
Employers involved in value purchasing activities
take widely divergent approaches, depending heavily on
their influence and on prevailing market conditions.
Some work at the hospital level; others deal with plans.
Some purchasers confine their scope to consumer
satisfaction, which is relatively easy to measure and
which, these employers feel, more closely reflects the
experience and perceptions of their employees. As
mentioned, many purchasers are interested in HEDIS
data. Several are now focusing their efforts on the

consumer-oriented outcomes-based measures developed
by the Foundation for Accountability (FACCT), a notfor-profit coalition of purchasers and consumer organizations. Some employers are targeting big-ticket
conditions and procedures, such as heart disease and
bypass surgery, or ones that are linked with workplace
productivity, such as depression and asthma.
For plans and providers, the rub is that little of this
activity appears to be making an impact on purchasing
decisions. Price, according to the experts, still drives
the market, and employers have shown that they are
willing to switch health plans for small differences in
premium. Even in Cleveland, where the widely respected CHQC program has been collecting quality
data from hospitals for several years, these efforts
appear to have had “less effect on purchasers’ decisions
than on hospitals’ concern for their internal practices
and their reputations.”13 However, the CHQC data
appear to have had some effect on the composition of
plans’ provider networks.
Some observers point out that reliable data on quality
have not been available to employers for long. In addition, employers face numerous challenges in applying
outcomes and other quality data to purchasing decisions.
Judith H. Hibbard, a professor of health policy at the
University of Oregon, found that most purchasers were
more likely to consider consumer satisfaction data and
accreditation status than outcomes or other clinical
quality data as quality determinants. In many cases,
employers said they did not feel these data were timely
or relevant to their needs. Hibbard also observed that
some employers simply did not have the time or inclination to try to figure out how to incorporate these data
into complex purchasing decisions. In addition, she
noted that the use of performance data varies substantially among purchasers and is changing constantly.14
It is important to keep in mind that employers are
not in business simply to purchase health care. They
purchase health care mainly because they feel they have
to, and usually only the price of that service has a direct
bearing on their ability to do business. This order of
priorities not only diminishes the relevance of quality
information, which is often difficult to apply in purchasing decisions, but also puts employers at odds with
their employees, who bear little of the direct cost of
health care.
That “disconnect” in interests is exacerbated by the
fact that, when it comes to health care, employers and
consumers face different kinds of decisions. Up to 70
percent of all employers offer their employees only one
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insurance carrier; that insurer frequently is forced to
accommodate consumer demands for greater choice by
serving up multiple plans with broad, overlapping
networks that include virtually every provider in the
local market.15 Meanwhile, the production of publicly
available data has shifted its emphasis from hospitals
and physicians to health plans. As a result, most employers have become more focused on measuring
quality at the plan level, which is where they make their
purchasing decisions. But consumers generally are
more interested in information at the provider level,
which, despite the restrictions of managed care, may be
where more of their choices lie. An initiative by the
PBGH and an accreditation group called the Medical
Quality Commission attempted to address this conflict
by measuring and reporting consumers’ perceptions of
individual physician groups’ performance.
Finally, most employers do not possess the purchasing clout or the internal resources of large companies
like Xerox or business coalitions like PBGH. These
smaller employers may have little choice but to continue basing their purchasing decisions mainly or even
solely on price.
How far employer-based efforts can go in promoting
and assuring healthcare quality remains to be seen. An
indicator may lie in purchasers’ response to impending
increases in healthcare premiums, the first in several
years.

ACCOUNTABILITY EFFORTS IN THE
PUBLIC SECTOR
Traditionally, the public-sector concept of accountability has been based on the regulatory and oversight
functions of government at the federal, state, and local
levels. These functions have taken on new dimensions
during the past half-dozen years, with the creation in
some states and localities of data agencies that produce
and report comparative data on healthcare quality. The
idea is that, armed with reliable data on quality, healthcare purchasers and consumers can make better-informed choices about health plans, hospitals, and
physicians. HCFA has also expressed interest in this
concept for Medicare.
The federal government’s efforts to monitor healthcare quality historically have been linked to its efforts
to control healthcare costs, beginning in the 1970s,
when rising Medicare costs led to demands for stricter
hospitalization review. The shape of Medicare’s quality
oversight program was largely determined by the

Medicare statute, which specifically bars the federal
government from exercising “any supervision or control
over the practice of medicine.” Because of this restriction, Medicare developed a quality assurance system
that relied heavily on peer review by providers, rather
than on examination of medical practice by the federal
government.16
In 1970, Experimental Medicare Care Review
Organizations (EMCROs), voluntary physician associations, were established under a demonstration program
to review services funded by Medicare and Medicaid.
The EMCROs became the model for the Professional
Standards Review Organizations (PSROs) created by
Congress to review not only the utilization but the
quality of institutional health care provided under
Medicare. The PSROs were federally funded, voluntary, not-for-profit, local organizations of physicians
that conducted reviews within specific geographic
regions.
In 1983, Medicare adopted the Prospective Payment
System for hospitals. Again, efforts to control costs
sparked fears about their effect on quality, and in 1986
Congress replaced the PSROs with the Peer Review
Organization (PRO) program to monitor the quality of
care provided to Medicare beneficiaries and to check
for abuses such as premature discharge and early
readmission. HCFA developed highly detailed review
procedures for the PROs based on examination of
medical records of selected cases by trained nurses
using quality-related screening criteria, notes Timothy
P. Hofer, M.D., of the University of Michigan, Ann
Arbor. But this system was viewed as punitive and
geared toward the identification of “bad apples.” In
recent years, the PROs—now known as Quality Improvement Organizations—have become increasingly
involved in local quality improvement initiatives with
Medicare providers under HCFA’s Health Care Quality
Improvement Program (HCQIP), which was created to
promote continuous improvement of care.
In 1986, when HCFA released its first hospital
mortality report rating hospitals in terms of their riskadjusted mortality rates, the report drew heavy criticism
from the industry for serious methodological flaws. In
subsequent reports, HCFA worked to correct those
flaws and refine its risk-adjustment methodology. These
reports were discontinued in 1993 after Bruce Vladeck
became HCFA’s administrator. Vladeck, formerly with
the New York Hospital Fund, felt that the reporting
methodology still failed to adjust adequately for the risk
factors of hospitals that served indigent populations. He
also expressed a desire to expand HCFA’s quality
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reporting activities beyond mortality rates to include
other, more comprehensive measures of quality.17
Meanwhile, interest in new outcomes measures,
risk-adjustment models, and data-collection methods
increased throughout the private and public sectors. In
1989, Congress created the Agency for Health Care
Policy and Research (AHCPR) within the U.S. Public
Health Service. Its mission is to improve the quality,
appropriateness, and effectiveness of health care, and to
improve access to healthcare services. The agency
supports and conducts health services research
—including medical effectiveness research—and
assessments of health technologies; it also supported for
several years the development of clinical practice
guidelines. AHCPR’s guideline activities on several
occasions drew fire from medical specialty groups
whose incomes were threatened by the agency’s recommendations. In 1996, AHCPR, after surviving several
budget cuts and changes in political fortune, abandoned
its guideline work in favor of a new program to promote
evidence-based medicine. Under this program, AHCPR
sponsors 12 Evidence-based Practice Centers in the
United States and Canada to review scientific literature
on specific medical topics, conduct additional analyses
when appropriate, and publish their findings in “evidence reports or technology assessments.”18
Quality measurement and reporting figured heavily
in the Clinton health reform proposal of 1993, which
outlined an ambitious national quality management
program that would have relied on a broad range of
performances measures and reporting initiatives to help
restructure the delivery system. That proposal made
accountability the new slogan for the healthcare industry and called for many levels of performance reporting
by the federal government, the states, regional health
alliances, plans, and providers. In keeping with the
administration’s plan to reform healthcare delivery
through a combination of managed competition and
government regulation, the proposed quality management program was comprehensive and complex. It
would have required universal data collection and the
creation of a national network of regional health data
systems to produce performance report cards.
Details of the proposed National Quality Management Program were never fully fleshed out; many of the
issues addressed then remain unresolved. Yet the
proposal triggered strong reactions throughout the
industry. Some people were angered by what they
viewed as a move to increase government regulation
and bureaucracy; others were frightened at the prospect

of meeting the proposal’s data demands. Whether in
support, opposition, or fear, various sectors of the
healthcare industry responded to Clinton’s promotion of
managed competition and accountability by stepping up
their own efforts to define and measure quality and
report their findings to numerous audiences.
In 1996, continued dramatic changes in the health
care system and public skepticism about managed care
prompted the appointment of the President’s Advisory
Commission on Consumer Protection and Quality in the
Health Care Industry. The 32-member commission was
established to “advise the President on changes occurring in the health care system and, where appropriate, to
make recommendations on how best to promote and
assure consumer protection and health care quality.” In
November 1997, the advisory commission unveiled a
proposal for a “consumer bill of rights and responsibilities,” which included the right for consumers to receive
accurate and easily understood information about
quality from their plans and providers.
But the advisory commission’s final report and
recommendations, which are to be submitted to the
president by March 30, 1998, are expected to be much
more comprehensive and to address issues such as quality measurement, monitoring, and improvement and the
role of public and private purchasers and oversight
organizations in promoting quality. In the recommendation being considered by the commission to create two
complementary bodies on healthcare quality—one
lodged in the public sector and the other in the private
sector—both entities would include representatives from
the public and private sectors. However, the publicsector body would take the lead in promoting and
guiding continuous improvement activities and the
private-sector body would focus on improving the
effectiveness and efficiency of healthcare quality
measurement and reporting.
Meanwhile, the Balanced Budget Act of 1997
includes a mandate for HCFA to establish quality requirements for health plans that enroll Medicare and
Medicaid beneficiaries. The Quality Improvement System in Managed Care will require participating plans to
show proof of improvement in the services they provide
and eventually will produce comparative performance
report cards of plans for consumers. Although the new
quality standards, which are to take effect in 1999, are
aimed primarily at managed care plans, a similar system
is being developed for fee-for-service care.19
More congressional action on quality may be in
store. The draft Senate bill being circulated by Lieber-
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man and Jeffords would establish a Health Quality
Council to “provide expertise in the areas of health care
quality measurement, the purchase, delivery and regulation of health care, as well as the health needs and
requirements of participants and beneficiaries.” With
support from AHCPR and in consultation with accreditation groups, employers, providers, health plans,
regulators, consumers, and others, the new council
would act as both a developer of and a clearinghouse
for information on quality standards, criteria, and
benchmarks.
In recent years, many government entities have
become more discriminating and more demanding
purchasers of healthcare services for beneficiaries and
employees. As a result, the public-sector concept of
accountability has evolved to encompass the function of
government as a purchaser.
Because of their multiple and developing roles in
assuring healthcare quality, government agencies are
involved in a wide range of initiatives to develop, test,
and apply quality measures and collect and report
healthcare data. Many of these activities are collaborative efforts with private sector actors, including providers, plans, employers, researchers, and accreditation
organizations. HCFA has taken the lead here.
HCFA’s Health Care Quality Improvement Program
is dedicated to assuring high-quality care for Medicare
and Medicaid patients by focusing on outcomes measurement and improvement. HCQIP sponsors cooperative projects on measuring and evaluating processes and
outcomes of care with HCFA’s PROs and end-stage
renal disease networks. More than 700 quality improvement projects were under way during the most recent
three-year cycle,20 including the Cardiovascular Cooperative Project, a national, data-based effort to improve
care for Medicare patients hospitalized for heart attacks, and a physician office profiling system designed
for Medicare.
In Medicaid, a three-state demonstration called the
Quality Assurance Reform Initiative tested a CQI
framework that included indicators borrowed largely
from HEDIS to monitor and improve Medicaid managed care. These indicators were to serve as the basis
for targeted quality-of-care studies and subsequent CQI
activities.
On the regulatory front, HCFA is proposing to
revise its rules for condition of participation in Medicare in four areas: home health, hospital care, hospice
care, and end-stage renal disease. These rules would
transform the process for Medicare certification,

placing more emphasis on patient care and patients’
experience with care. For example, the proposed home
care rule—the only one published so far—would
require Medicare home health agencies to use a standard system called the Outcomes and Assessment
Information Set (OASIS) to measure quality and patient
satisfaction with care. A new proposal would merge
OASIS with the Minimum Data Set system used for
nursing homes. If approved, these rules may force
accreditation groups that have “deemed status” relationships with Medicare and Medicaid—that is, where
satisfaction of the organization’s accreditation standards
is deemed to satisfy federal requirements—to revise
their own standards to meet Medicare’s new conditions
of participation.
Most significantly, perhaps, HCFA has started to
become a more assertive purchaser of services from
risk-based contractors. Although Medicare does not
competitively select health plans based on quality, it has
raised its contracting requirements in that area through
mandatory reporting of HEDIS data and the new Consumer Assessment of Health Plans Survey (CAHPS).
The FACCT measures, which HCFA is evaluating in a
collaborative study, may eventually become another
reporting requirement for Medicare participation.
Together, HEDIS, CAHPS, and the FACCT measures
would supply HCFA with a three-pronged strategy for
holding Medicare contractors to a higher level of
accountability through data collection.
In addition, HCFA has played an active role in the
development of new HEDIS measures, particularly
those measures designed specifically for Medicare and
Medicaid. HEDIS 3.0 is the first version of HEDIS that
includes Medicare measures; a Medicaid version of
HEDIS was issued in February 1996 and is a reporting
requirement in many states.
It should be noted that HCFA’s efforts to assure
accountability apply to both its managed care and its
fee-for-service programs. Although Medicare managed
care enrollment is increasing (about 5 million people
are signed up with 336 plans nationwide), 87 percent of
Medicare beneficiaries still receive care through traditional fee-for-service insurance.21 HCFA is investigating the application of HEDIS in fee-for-service settings.
In addition, FACCT’s measures are designed for use in
both managed care and fee-for-service environments.
Working with NCQA, FACCT, private employers,
and others, HCFA hopes to rally purchasers in identifying a universal set of quality measures and methodologies. “HCFA is going to lead the effort among all these
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purchasers to converge the list of measures—whether
they be procedural or outcomes-focused—and have
everyone agree that that’s what they’re going to report,”
predicts John Gorman, formerly of HCFA’s Office of
Managed Care. The FACCT evaluation provides an
example of how HCFA hopes to accomplish this feat.
HCFA has encouraged other purchasers to participate
in the project, and purchaser interest in participation
helped guide site selection.
HCFA’s ambitious agenda may conflict with the
incremental, pragmatic approaches pursued by many
private-sector purchasers throughout the country. It
remains to be seen whether these various pursuits can
be successfully dovetailed to the satisfaction of purchasers in both the public and the private sectors.
Like HCFA, state governments are engaged in a
number of roles related to measuring, monitoring, and
assuring healthcare quality and, in rare cases, using
quality as a basis for healthcare purchasing. These
activities vary widely by state and for the most part are
not coordinated.
Most state Medicaid agencies collect data on utilization, outcomes, consumer satisfaction, and disenrollment; they all conduct chart reviews. The spread of
managed care in Medicaid programs has complicated
some of these data collection activities, because claims
records, a key source for many of these data, are not
generated automatically for payment under capitated
systems. Nevertheless, public skepticism about managed care and a new emphasis on community-based
care have increased pressures on Medicaid agencies to
engage in collaborative quality improvement initiatives
with health plans, providers, public health agencies, and
community organizations in areas such as pediatric
immunization and prenatal care.
Some state Medicaid agencies are also trying to
incorporate quality-based performance indicators and
specifications into their contracting strategies. These
approaches vary considerably. Several states are using
quality determinants to assess potential contractors. For
example, Arizona’s Medicaid agency applies a selective
contracting evaluation formula that assigns a weight of
about 70 percent to quality and access criteria and 30
percent to cost. Other states, such as Massachusetts,
Washington, and Oregon, are using performance
measurement to manage their Medicaid contracts. For
example, Massachusetts holds Medicaid contractors
accountable for measurable service improvements that
are spelled out in a set of contractual terms and purchasing specifications.22 The quality component of these

terms requires contracting plans to provide member
satisfaction data, clinical indicator data from HEDIS,
and voluntary disenrollment rates.
In addition, a number of state legislatures have
created health data entities that collect and report
certain outcomes and other data from healthcare organizations. The scope and responsibilities of these data
collection agencies vary. Examples include the Pennsylvania Health Care Cost Containment Council, which
publishes comparative quality and cost reports on
hospital, physician, and plan services; the Minnesota
Health Data Institute, which uses consumer-based
surveys to produce detailed plan-specific performance
reports; and the Maryland Health Care Access and Cost
Commission, which uses HEDIS data, enrollee data,
and provider surveys to generate comparative plan
performance reports.
Public health agencies are also becoming more
active in quality measurement and reporting activities.
Some public health agencies are just beginning to build
data linkages with managed care plans that can support
public health objectives and activities. In addition to the
barriers faced by other users of healthcare data, many of
these agencies are struggling with severe budget cuts.
Still, some efforts have taken shape and most of them
are using HEDIS as a blueprint for their data collection
activities. Missouri appears to have advanced the
furthest in this respect. Providers, plans, purchasers, and
public health officials there have collaborated to develop their own Missouri Health Indicator Set for
quality assessment. Public health records on births,
deaths, hospital discharges, and cancer are being eyed
to supply some of the needed data.
Although public health agencies in states like
Missouri are starting to make progress in establishing
data links that will enable them to monitor communitybased public health, it undoubtedly will take several
years for these efforts to bear fruit. However, the
creation of these data links would benefit managed care
organizations, which increasingly are emphasizing
community-based care that requires community-based
numerator data for quality assessment. These plans in
time may begin to invest more resources in establishing
data partnerships with public health agencies.
Clearly, public-sector agencies play a significant
role in the quality measurement arena. But, like many
initiatives in the private sector, these public-sector
activities are diverse, driven by multiple agendas and,
for the most part, uncoordinated. At the state and local
levels, views on healthcare quality and commitments to
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data collection vary considerably and are subject to
change over time.
At the federal level, important questions remain
about what the role of government should be in establishing, monitoring, and reporting on health care
accountability. Should government act as a clearinghouse for data on healthcare quality? Should it decide
what measures will be used to define quality across
various settings? Or should it attempt to forge consensus among the various interest groups by weight of its
purchasing power through Medicare?

OVERARCHING ISSUES
Efforts to measure and report healthcare quality
invariably confront a wide range of complex issues,
including scope, funding, the type of data to be collected, the method of collection, data terms and definitions, timing, risk adjustment, and how the data will be
released and to whom. Some of these decisions are
highly technical; others are political. How these decisions are made largely depends on who is leading the
effort and what its objectives are. According to several
observers, it is more important for participants in
quality initiatives to achieve consensus on these fundamental issues than it is to achieve technical perfection.
“It doesn’t matter what [risk] models you use or what
[computer] system you use, as long as all the players
agree,” asserts Dwain L. Harper, executive director of
the Cleveland Health Quality Choice Program.23
There is still disagreement on what types of measures are most appropriate for evaluating healthcare
quality and whether the state of the art is sufficiently
advanced to meet the demands of multiple data users.
HEDIS, the FACCT measures, CAHPS, and health
status assessment surveys such as the SF-36 are among
the more widely used measurement tools. Certainly, a
great many more measurement sets are in use; the
CONQUEST database maintained by AHCPR has
identified more than 1,100 clinical quality measures
contained in some 50-odd measurement sets. These
measures reflect different views about what dimensions
of quality are important to evaluate, what unit of
analysis (that is, plan, physician, or hospital) should be
used, the feasibility of various data sources, and the
information needs of the particular user.
A critical obstacle to resolving data collection issues
stems from inadequate investment in sufficiently
sophisticated and compatible information systems.
NCQA maintains:

The shortcomings of existing sets of performance
measures are not so much due to lack of science,
imagination, or political will, but to constraints posed
by poor information systems—the measures that can
be accomplished using today’s systems are necessarily
weak and sparse and will remain so until information
systems are widely used, and information frameworks
are created.24

The importance of investing in information systems
is illustrated by the experience of the PBGH and the
Medical Quality Commission. The two organizations
collaborated on a project to measure consumer-based
perceptions of quality in a random survey of 55,000
managed care enrollees, 1,000 from each of 55 participating physician groups. Project directors say that many
physician groups had difficulty supplying the enrollment data needed to launch the study, the first of its
kind in terms of measuring consumer-rated quality at
the group level.25 Similarly, many health plans—large
and small—do not have information systems that are
sufficiently sophisticated to participate in aggressive
data collection initiatives.
Where such systems are in place, they generally
cannot be linked. This is a problem in both the public
and the private sectors. As mentioned, state and local
public health agencies are just beginning to build data
linkages with managed care plans to support
community-based health assessment and management;
these efforts face many financial and logistical barriers.
Purchasers, too, have identified similar difficulties. The
National Business Coalition on Health says that “the
establishment of linkages and networks among data
sources” will be critical to supporting value purchasing
activities.26
Widespread interest in HEDIS data by employers
and HCFA is increasing the pressure on health plans to
invest in better information systems. In addition, efforts
to develop standardized clinical data sets will help solve
data collection and transmission problems. To that end,
the Health Insurance Portability and Accountability of
Act mandates the setting of standards for electronic
transmission of health information for computer-based
medical records by August 2000.27
Inability to come to terms with these overarching
issues is holding back progress in both the public and
private sectors. Yet it is likely that some of these issues
will remain moving targets because of constant change
in the healthcare industry and the ever-evolving nature
of science and technology. New and better measures
will always be sought; there is no such thing as a
“perfect” risk adjustment model, and it appears that
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there will always be room for a bigger, faster, and more
powerful computer system. Perhaps with adequate
levels of commitment and collaboration, various actors
within the healthcare industry may at least work to
advance these issues in the same general direction.
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